Overview

Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer

Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Elderly patients with esophageal cancer will receive thoracic radiation therapy 54-60Gy over 30 fractions, and concurrent with Gefitinib.
Phase:
Phase 2
Details
Lead Sponsor:
Zhejiang Cancer Hospital
Treatments:
Gefitinib